Prostate tumor delineation using multiparametric magnetic resonance imaging: Inter-observer variability and pathology

Peter Steenbergen1, Karin Haustermans2, Evelyne Lerut3

  • 1Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Summary

Radiotherapy dose escalation to dominant prostate cancer lesions is feasible, as most dominant tumors were consistently identified by multiple teams on MRI. However, maintaining whole prostate coverage is crucial to address smaller or undetected lesions.